V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006074 | 200011371 | 1.7 | 78 | null | 2021-11-13 | 2021-12-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100118142 |
| 200006076 | 200011373 | 1.63 | 59.1 | Disease modification (D) | 2020-02-19 | 2020-02-21 | Trial Unspecified | 02 | null | IPILIMUMAB | 100358602 |
| 200006078 | 200011375 | 1.69 | 80 | null | 2016-03-10 | 2016-03-19 | DABRAFENIB | 02 | null | DABRAFENIB | 100970394 |
| 200006079 | 200011376 | 1.67 | 104.5 | Palliative (P) | 2018-01-30 | 2018-02-07 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101024941 |
| 200006080 | 200011377 | 1.64 | 130 | Palliative (P) | 2017-04-26 | 2017-08-20 | DABRAFENIB | 02 | null | DABRAFENIB | 100139413 |
| 200006082 | 200011379 | 1.66 | 89.2 | 03 | 2018-12-29 | 2019-01-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101506790 |
| 200006083 | 200011380 | 1.83 | 69 | Palliative (P) | 2019-04-17 | 2019-04-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101212390 |
| 200006085 | 200011382 | 1.65 | 137.8 | Palliative (P) | 2020-10-28 | 2020-11-21 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100558430 |
| 200006088 | 200011385 | 1.76 | 67 | Adjuvant (A) | 2020-01-25 | 2020-01-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101205997 |
| 200006090 | 200011387 | 1.67 | 74 | Palliative (P) | 2021-06-17 | 2021-07-08 | DABRAFENIB | 02 | null | DABRAFENIB | 100512820 |
| 200006091 | 200011388 | 0 | 109.3 | Palliative (P) | null | 2019-06-08 | null | null | null | BINIMETINIB + ENCORAFENIB | 100493082 |
| 200006093 | 200011390 | null | 62.8 | Palliative (P) | 2020-05-01 | 2020-05-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100005705 |
| 200006095 | 200011392 | 1.71 | 48.4 | Palliative (P) | 2017-07-24 | 2017-07-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100473694 |
| 200006097 | 200011394 | 1.83 | 100 | null | 2018-06-05 | 2019-05-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100154485 |
| 200006099 | 200011396 | 1.64 | 87.3 | Palliative (P) | 2022-02-17 | 2022-02-17 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101845088 |
| 200006100 | 200011397 | null | null | null | null | 2017-05-17 | null | null | null | BINIMETINIB + ENCORAFENIB | 101760532 |
| 200006101 | 200011398 | null | 43.4 | Palliative (P) | 2016-08-01 | 2016-08-22 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100267795 |
| 200006103 | 200011400 | 1.7 | 61.6 | null | 2017-10-21 | 2018-09-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100639155 |
| 200006104 | 200011401 | null | 72 | Adjuvant (A) | null | 2017-07-03 | null | null | N | BINIMETINIB + ENCORAFENIB | 101556373 |
| 200006106 | 200011403 | 1.83 | 168.8 | Adjuvant (A) | 2017-06-14 | 2017-06-16 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100732631 |
| 200006107 | 200011404 | 1.69 | 62 | Palliative (P) | 2021-10-04 | 2021-10-25 | DABRAFENIB | 02 | N | DABRAFENIB | 100894746 |
| 200006108 | 200011405 | 0 | 0 | Palliative (P) | 2018-11-04 | 2018-11-18 | DABRAFENIB | 02 | null | DABRAFENIB | 101822703 |
| 200006110 | 200011407 | 1.88 | 99.2 | Palliative (P) | 2019-06-30 | 2019-07-13 | DABRAFENIB | 02 | null | DABRAFENIB | 100994696 |
| 200006111 | 200011408 | 1.94 | 89.8 | Adjuvant (A) | 2020-01-02 | 2020-01-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100785747 |
| 200006114 | 200011411 | 1.68 | 80 | Palliative (P) | 2020-01-21 | 2020-02-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101596987 |
| 200006115 | 200011412 | 1.66 | 70.8 | Palliative (P) | 2018-01-16 | 2018-02-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100598520 |
| 200006116 | 200011413 | 1.7 | 102 | Palliative (P) | 2018-05-24 | 2018-06-14 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101451349 |
| 200006118 | 200011415 | 1.77 | 70.4 | Palliative (P) | 2016-11-05 | 2016-11-14 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101416374 |
| 200006124 | 200011421 | null | null | null | null | 2019-04-13 | null | null | null | BINIMETINIB + ENCORAFENIB | 100081113 |
| 200006125 | 200011422 | 1.68 | 72.5 | 03 | 2016-12-31 | 2017-01-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101538869 |
| 200006126 | 200011423 | null | 96 | Palliative (P) | 2018-02-06 | 2018-02-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101413775 |
| 200006127 | 200011424 | null | 79.5 | Palliative (P) | 2017-08-20 | 2017-09-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100110255 |
| 200006128 | 200011425 | 1.68 | 63 | null | 2019-12-07 | 2019-12-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101012400 |
| 200006130 | 200011426 | 1.83 | 68 | null | 2017-03-28 | 2017-05-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101192537 |
| 200006131 | 200011427 | null | 93.1 | Palliative (P) | 2017-09-25 | 2017-10-21 | IPILIMUMAB + NIVOLUMAB | 01 | N | TRIAL UNSPECIFIED | 101859991 |
| 200006135 | 200011431 | null | 63 | null | 2020-01-13 | 2020-01-13 | TALIMOGENE LAHERPAREPVEC | 02 | null | IPILIMUMAB + NIVOLUMAB | 101608433 |
| 200006138 | 200011434 | 1.8 | 107 | Disease modification (D) | 2019-06-09 | 2019-06-18 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 01 | null | TRIAL UNSPECIFIED | 101366725 |
| 200006142 | 200011438 | 1.65 | 92.6 | Palliative (P) | 2017-04-08 | 2019-03-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101431383 |
| 200006143 | 200011439 | 1.71 | 69.2 | Palliative (P) | 2019-10-20 | 2019-10-20 | DABRAFENIB | 02 | null | IPILIMUMAB | 101642117 |
| 200006145 | 200011441 | 1.68 | 91.7 | Adjuvant (A) | 2015-11-01 | 2016-09-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101142457 |
| 200006146 | 200011442 | 1.81 | 101 | Palliative (P) | 2016-12-23 | 2017-01-20 | Binimetinib + Encorafenib | N | null | DABRAFENIB | 100354648 |
| 200006149 | 200011444 | 1.8 | 99 | 03 | 2019-09-03 | 2019-09-14 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101066883 |
| 200006151 | 200011446 | 1.78 | 95.5 | null | 2019-12-31 | 2020-01-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101720970 |
| 200006153 | 200011448 | null | null | null | null | 2019-04-21 | null | null | null | NILOTINIB | 101188323 |
| 200006154 | 200011449 | 1.56 | 54 | Palliative (P) | null | 2020-02-21 | null | null | null | BINIMETINIB + ENCORAFENIB | 100319156 |
| 200006155 | 200011450 | 1.77 | 72.9 | Palliative (P) | 2017-10-03 | 2017-11-02 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100189723 |
| 200006156 | 200011451 | 1.72 | 89.8 | Palliative (P) | 2020-02-05 | 2020-03-09 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100412636 |
| 200006157 | 200011452 | null | 109.2 | Palliative (P) | 2020-11-24 | 2020-11-29 | Dacarbazine | 02 | null | DABRAFENIB | 100612596 |
| 200006158 | 200011453 | 1.57 | 101 | Curative (C) | null | 2019-01-13 | DABRAFENIB | 02 | null | DABRAFENIB | 101092425 |
| 200006159 | 200011454 | 1.41 | 55 | Palliative (P) | 2021-07-23 | 2021-10-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101196930 |